Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
Actual shortage: | 240 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2023-11-03 | 2024-03-07 | 209122 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2024-01-25 | 209125 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2023-11-23 | 209130 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2024-01-25 | 209133 |
TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2023-11-03 | 2024-04-18 | 209136 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-11-03 | 2023-12-14 | 209139 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-11-03 | 2023-12-14 | 209142 |
TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2023-11-03 | 2024-01-19 | 209145 |
TEVA-NAPROXEN | 375MG | TABLET | Resolved | 2023-11-09 | 2024-01-11 | 209661 |
TEVA-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2023-11-09 | 2023-12-14 | 209669 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-09 | 2023-12-07 | 209672 |
TEVA-METFORMIN | 850MG | TABLET | Resolved | 2023-11-09 | 2024-05-09 | 209675 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2023-11-16 | 2023-12-14 | 210428 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-11-16 | 2023-11-23 | 210431 |
TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2023-11-16 | 2023-12-14 | 210434 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-11-16 | 2023-12-14 | 210437 |
TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-11-16 | 2024-03-28 | 210440 |
TEVA-CEPHALEXIN 125 | 125MG | POWDER FOR SUSPENSION | Resolved | 2023-11-23 | 2024-03-28 | 211316 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2023-11-23 | 2024-01-11 | 211319 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-11-23 | 2023-12-14 | 211322 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |